A Network Meta-analysis Comparing the Efficacy and Safety of Anti-PD-1 with Anti-PD-L1 in Non-small Cell Lung Cancer

Background: This network meta-analysis aimed at comparing anti-programmed death 1 (anti-PD-1) with anti-programmed death ligand 1(anti-PD-L1) immunotherapy in patients with metastatic, previously treated non-small cell lung cancer (NSCLC) who failed first-line treatment. Methods: We searched electro...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Wei, Liu, Mei, Miao, Ji-Dong, Liao, Yu-Qian, Song, Yi-Bing, Cai, Dian-Kun, Gao, Yang, Peng, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907668/
https://www.ncbi.nlm.nih.gov/pubmed/29675101
http://dx.doi.org/10.7150/jca.22361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907668/
https://www.ncbi.nlm.nih.gov/pubmed/29675101
http://dx.doi.org/10.7150/jca.22361

Ejemplares similares